Clara Crespillo-Andujar
Overview
Explore the profile of Clara Crespillo-Andujar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Sanz M, Martin-Rubio I, Martin O, Muriel A, de la Fuente-Hernanz S, Crespillo-Andujar C, et al.
Trop Med Infect Dis
. 2025 Jan;
10(1).
PMID: 39852673
Background: Chronic schistosomiasis can lead to significant morbidity. Serology is highly sensitive; however, its role in assessing treatment response is controversial. This study aimed to analyze serological values following treatment...
2.
Camprubi-Ferrer D, Diaz Menendez M, Crespillo-Andujar C, Galparsoro H, Belhassen-Garcia M, Cuadros Gonzalez J, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 Jul;
42(7):380-385.
PMID: 38965027
The Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Emergency Medicine (SEMES), the Spanish Society...
3.
Corbacho-Loarte M, Martin O, Chamorro-Tojeiro S, Crespillo-Andujar C, Norman F, Perez-Molina J, et al.
Malar J
. 2024 Jun;
23(1):179.
PMID: 38844954
Background: In non-endemic countries, malaria can be transmitted through blood donations from imported cases. To ensure standards of quality and safety of human blood, the European Union and Spanish national...
4.
Pinazo M, Forsyth C, Losada I, Esteban E, Garcia-Rodriguez M, Villegas M, et al.
Lancet Infect Dis
. 2024 Jan;
24(4):395-403.
PMID: 38218194
Background: More than six million people worldwide, particularly in vulnerable communities in Latin America, are infected with Trypanosoma cruzi, the causative agent of Chagas disease. Only a small portion have...
5.
Gonzalez-Sanz M, Crespillo-Andujar C, Chamorro-Tojeiro S, Monge-Maillo B, Perez-Molina J, Norman F
Trop Med Infect Dis
. 2023 Dec;
8(12).
PMID: 38133445
Chagas disease is currently present in many non-endemic countries and remains a neglected tropical disease globally. A review of the literature identified significant gaps and scarcity of updated information from...
6.
Norman F, Gonzalez-Sanz M, Gullon-Pena B, Chamorro-Tojeiro S, Rosas M, Crespillo-Andujar C, et al.
J Travel Med
. 2023 Aug;
30(7).
PMID: 37615968
No abstract available.
7.
Perez-Molina J, Crespillo-Andujar C, Trigo E, Chamorro S, Arsuaga M, Olavarrieta L, et al.
PLoS Negl Trop Dis
. 2023 Jul;
17(7):e0011490.
PMID: 37478160
Background: The implications of the gut microbial communities in the immune response against parasites and gut motility could explain the differences in clinical manifestations and treatment responses found in patients...
8.
Perez-Molina J, Crespillo-Andujar C, Zamora J, Fernandez-Felix B, Gaetano-Gil A, Lopez-Bernaldo de Quiros J, et al.
Clin Infect Dis
. 2023 Mar;
76(11):2027-2037.
PMID: 36975712
We assessed whether low CD4 count and high viral load (VL) affect the response to currently preferred ART. We performed a systematic review of randomized, controlled clinical trials that analyzed...
9.
Corbacho-Loarte M, Crespillo-Andujar C, Chamorro-Tojeiro S, Norman F, Perez-Molina J, Martin O, et al.
Travel Med Infect Dis
. 2022 Aug;
49:102411.
PMID: 35933089
Background: Up to 40% of cases of imported malaria in Europe are diagnosed in recently arrived migrants, who generally exhibit asymptomatic or mild symptoms and show low parasitaemia (submicroscopic). The...
10.
Crespillo-Andujar C, Comeche B, Hamer D, Arevalo-Rodriguez I, Alvarez-Diaz N, Zamora J, et al.
PLoS Negl Trop Dis
. 2022 May;
16(5):e0010386.
PMID: 35576215
Background: Approximately 6 million people worldwide are affected by Chagas disease, with many in the chronic phase of the disease (CCD). It is crucial to evaluate the effectiveness of benznidazole...